Home Search
vaccine - search results
If you're not happy with the results, please do another search
What are the side effects of the Pfizer booster vaccine?
Here, we explain side effects of the Pfizer booster vaccine – with a look at how they impact menstrual cycles.
Moderna aim to make combined flu-COVID vaccine for 2023
Speaking at the World Economic Forum, CEO Stéphane Bancel said Moderna aim to create a combined flu and COVID vaccine.
Study finds three doses of Pfizer vaccine can handle Omicron
New data suggests that the Pfizer and BioNTech vaccine, at three doses, is enough to stop the Omicron variant from creating severe COVID.
Vaccine passports: Reimagining their cybersecurity
Jonathan Jackson, BlackBerry, looks at how vaccine passports and digital vaccine certificates could work - while facing off with cyber-criminals across the world.
Over 100 Global South factories could make mRNA vaccines
Médecins Sans Frontières (MSF) found that over 100 manufacturers in Asia, Africa and Latin America are capable of making mRNA COVID vaccines - but pharmaceutical companies won't waive intellectual property rights.
Universal COVID vaccines can learn from the common cold
Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.
COVID vaccine can cause temporary change to menstruation cycle
Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.
Convidecia vaccine 57.5% effective against symptomatic COVID
Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.
European Commission approves Novavax COVID vaccine for use
The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.
What are the side effects of the Moderna booster vaccine?
Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.
The UK health charities advancing vaccine uptake
Health charities have come into collaboration with the government and the NHS to promote and advance vaccine update, as UK hits its next milestone in the vaccine rollout.
COVID vaccine: Parental hesitancy for kids with cancer
A survey shows parents of kids with cancer have similar hesitancy rates as the wider population to vaccinate their children against COVID-19.
Scientists develop new potential vaccine for Alzheimer’s
A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
Study connects housing insecurity to vaccine hesitancy in Black communities
Research by Augusta University, published in Vaccines, found that housing insecurity is connected to vaccine hesitancy in Black communities - especially when it comes to the younger population.
Emphasising vaccines and immunotherapeutics research worldwide
Here, Open Access Government interview Dr Babita Agrawal, Professor in the Department of Surgery, University of Alberta to discuss the continued need for research into vaccines and immunotherapeutics.
New “clickable” COVID vaccine patch in early stages of testing
The University of Texas is creating a COVID vaccine patch, which can protect against the virus - without the use of a needle.
Risk of pregnancy loss not associated with COVID-19 vaccines
According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.
First malaria vaccine offers “glimmer of hope” to millions
The World Health Organisation has recently authorised a malaria vaccine, RTS,S/AS01, which has been successful in pilot schemes launched in 2019.
Study finds Pfizer vaccine works at 90% efficacy for six months
The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.
Scientists create experimental vaccine for rheumatoid arthritis
The scientists found that "rheumatoid arthritis totally disappeared" in animals that were given the vaccine - creating hope for a functional vaccine.